| PRWCX | RBAIX | PRWCX / RBAIX | |
| Total Expense Ratio | 0.71 | 0.47 | 151% |
| Annual Report Gross Expense Ratio | 0.74 | 0.52 | 142% |
| Fund Existence | 40 years | 10 years | - |
| Gain YTD | 3.553 | 10.387 | 34% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 500000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 71.4B | 5.06B | 1,411% |
| Annual Yield % from dividends | 1.92 | 2.03 | 95% |
| Returns for 1 year | 2.28 | 9.14 | 25% |
| Returns for 3 years | 25.76 | 36.13 | 71% |
| Returns for 5 years | 13.47 | 16.49 | 82% |
| Returns for 10 years | 63.34 | 58.14 | 109% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VLUE | 138.20 | 0.93 | +0.68% |
| iShares MSCI USA Value Factor ETF | |||
| FTXH | 33.54 | 0.22 | +0.66% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| QBUF | 29.63 | 0.09 | +0.31% |
| Innovator Nasdaq-100 10 Buffr ETF - Qt | |||
| LSGR | 45.43 | 0.09 | +0.20% |
| Natixis Loomis Sayles Focused Growth ETF | |||
| BSMW | 25.07 | -0.01 | -0.02% |
| Invesco BulletShares 2032 Muncpl Bd ETF | |||